Biotech's role in advancing HIV vaccine development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biotech's role in advancing HIV vaccine development

Published:2024-08-12 Issue:1 Volume:13 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Tatoud Roger¹^ORCID,Brander Christian²^ORCID,Hwang Carey³,Kennelly Jo⁴,Lu Shan⁵^ORCID,O’Neil Kevin⁶,Safrit Jeffrey T.⁷,Benhayoun Iris⁵,Firmat Julieta⁸^ORCID,Barriere Nelli⁸

Affiliation:

1. Origena Consulting, Ferney Voltaire, France

2. AELIX Therapeutics, Catalonia, Spain

3. Vir Biotechnology, San Francisco, CA, USA

4. Malaika Vx, Toronto, Canada

5. Worcester HIV Vaccine, Worcester, MA, USA

6. Uvax Bio, Newark, DE, USA

7. ImmunityBio, San Diego, CA, USA

8. International AIDS Society, Geneva Switzerland

Funder

International AIDS Society HIV Vaccine Industry Partnership Group

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2024.2384460

Reference26 articles.

1. Prevention, treatment and cure of HIV infection

2. Joint United Nations Programme on HIV/AIDS. HIV response sustainability primer [Internet]. Geneva; 2024 [cited 2024 Feb 7]. Available from: https://www.unaids.org/en/resources/documents/2024/20240117_HIV_response_sustainability.

3. HIV vaccinology: 2021 update

4. Current approaches to HIV vaccine development: a narrative review

5. Prophylactic HIV-1 vaccine trials: past, present, and future

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP